# FDA Inspection 1097017 - Lonza Biologics Plc - September 05, 2018

Source: https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/aa80e7f0-6a15-4745-a5cc-25cf870229f3
Source feed: FDA_Inspections

> FDA Inspection 1097017 for Lonza Biologics Plc on September 05, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097017
- Company Name: Lonza Biologics Plc
- Inspection Date: 2018-09-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1202907 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/520d5ebf-f785-4a4c-9a6f-8bb407ee99f1)
- [FDA Inspection 978909 - 2016-06-24](https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/4cdfb86e-483c-4c1c-9222-982dd09ae126)
- [FDA Inspection 801062 - 2012-09-24](https://www.keypedia.com/records/fda_inspections/lonza-biologics-plc/234c174a-5c7d-4088-a402-3faaa3a11ccf)

Company: https://www.keypedia.com/companies/lonza-biologics-plc/9bb3cb06-cade-452a-ba25-b43fec0aaa12

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c